IL6 and breast carcinoma: Silencing GRN also reduced experiments because it induces robust stimulation of IL-6 and OSM-induced STAT3 transcriptional activity as STAT3 tyrosine phosphorylation and is physiologically measured by luciferase reporter assay, indicating that this relevant in breast cancer cell proliferation [24, 25].